TBC
BMY icon

Tweedy, Browne Co’s Bristol-Myers Squibb BMY Stock Holding History

Tweedy, Browne Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Buy
26,158
+9,316
+55% +$543K 0.13% 57
2025
Q4 		$908K Buy
16,842
+2,376
+16% +$114K 0.07% 64
2025
Q3 		$652K Buy
14,466
+7,282
+101% +$340K 0.06% 81
2025
Q2 		$333K Buy
+7,184
New +$353K 0.03% 68

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tweedy, Browne Co's BMY Position: Q1 2026 in Review

Tweedy, Browne Co increased its Bristol-Myers Squibb (BMY) stake by 55% in Q1 2026, buying an estimated $543K and bringing the position to 26,158 shares worth $1.59M. The position accounts for 0.13% of the portfolio, ranked #57.

Tweedy, Browne Co first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Tweedy, Browne Co held 26,158 shares of Bristol-Myers Squibb worth $1.59M as of Q1 2026.
  • Tweedy, Browne Co bought 9,316 Bristol-Myers Squibb shares in Q1 2026, an estimated $543K.
  • Bristol-Myers Squibb made up 0.13% of Tweedy, Browne Co's portfolio in Q1 2026, its #57 holding.
  • Tweedy, Browne Co first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tweedy, Browne Co's 13F filing for Q1 2026, filed 6 May 2026.